160. Congenital ichthyosis
32 clinical trials,   62 drugs   (DrugBank: 18 drugs),   15 drug target genes,   107 drug target pathways

Other name(s) = "Keratinopathic ichthyosis", "Epidermolytic ichthyosis", "Harlequin ichthyosis", "Congenital Ichthyosiform Erythroderma", "Foliate ichthyosis", "Ichthyosis syndrome", "Netherton syndrome", "Sjogren-Larsson syndrome", "Sjögren-Larsson syndrome", "Keratitis-ichtyosis-deafness syndrome", "Dorfman-Chanarin syndrome", "Neutral lipid storage disease", "NLSD", "Multiple sulfatase deficiency", "Austin disease", "Recessive X-linked ichthyosis", "RXLI", "X-linked recessive ichthyosis", "Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature", "IBID", "Trichothiodystrophy", "Follicular ichthyosis", "Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome", "CHILD syndrome", "Conradi-Hunermann-Happle syndrome", "Conradi-Hünermann-Happle syndrome", "CHHS"

Specific pediatric chronic diseases, Japan
• 14-2-2. Keratinopathic ichthyosis, including Epidermolytic ichthyosis and Superficial epidermolytic ichthyosis
• 14-2-3. Autosomal recessive congenital ichthyosis, excluding Harlequin ichthyosis
• 14-2-4. Harlequin ichthyosis
• 14-2-5. Netherton syndrome
• 14-2-6. Sjögren-Larsson syndrome
• 14-2-7. Other congenital ichthyoses